MedLern and Asha Hospital Collaborate for Training Innovation

MedLern, the only medical education solution for hospitals and healthcare professionals, has entered into a strategic partnership with Asha Hospital, a healthcare facility accredited with NABH,

S&P Global Sustainability Yearbook 2024: Sun Pharma Inclusion

Sun Pharmaceutical Industries Limited has announced its inclusion in the SandP Global Sustainability Yearbook 2024. This yearbook aims to identify companies in each industry that have demonstrated a commitment to corporate sustainability.

BioInvent & AstraZeneca Partner for BI-1206 Combo Study

BioInvent International AB (BioInvent), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, has announced a clinical supply agreement

NIMHANS Wins WHO Mandela Health Promotion Award

The National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, has been awarded the Nelson Mandela Award for Health Promotion 2024 by the World Health Organization (WHO).

FDA Grants Priority Review for Humacyte's Acellular Vessel BLA

Humacyte, Inc., a clinical biotechnology foundation company developing bioengineered human tissues that can be transplanted commercially, has received in-principle approval of Humacyte's Biologics License Application (BLA)

Dr. SC Mandal Emphasizes Regulators' Role in Addressing AMR Menace

In light of the growing threat of antimicrobial resistance (AMR), drug regulators have an important role in addressing the current global threat, largely due to the misuse and underuse of antibiotics. Dr Subhash C Mandal is the chairman of Regulatory

Vicore Pharma Licenses C21 to Nippon Shinyaku for Japan

Vicore Pharma Holding AB, an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists (ATRAGs), has entered into an exclusive licensing agreement with Nippon S

Yatharth Hospital Acquires Asian Fidelis For Rs 116 crore

Yatharth Hospital and Trauma Care Services announced the all-cash acquisition of Asian Fidelis Hospital, a multi-specialty hospital with 175 beds in Faridabad, for Rs 116 crore. Yatharth Clinic said it has gone into a conclusive concurrence with...

Theriva Secures IDMC Recommendation For Enrollment in Phase 2b Trial

Theriva Biologics, a broadened clinical-stage organization creating therapeutics intended to treat malignant growth and related sicknesses in areas of high neglected need, declared that the Free Information Observing Panel (IDMC) suggested the...

Biocon Biologics Partners with Sandoz Australia for Biosimilars

pharmaceutical companies, high-quality biologics ,partnership

© 2024 India Pharma Outlook. All Rights Reserved.